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The SH2 domain of cytoplasmic tyrosine kinases can
enhance catalytic activity and substrate recognition,
but the molecular mechanisms by which this is
achieved are poorly understood. We have solved
the structure of the prototypic SH2-kinase unit of
the human Fes tyrosine kinase, which appears spe-
cialized for positive signaling. In its active conforma-
tion, the SH2 domain tightly interacts with the kinase
N-terminal lobe and positions the kinase aC helix in
an active configuration through essential packing
and electrostatic interactions. This interaction is sta-
bilized by ligand binding to the SH2 domain. Our data
indicate that Fes kinase activation is closely coupled
to substrate recognition through cooperative SH2-
kinase-substrate interactions. Similarly, we find that
the SH2 domain of the active Abl kinase stimulates
catalytic activity and substrate phosphorylation
through a distinct SH2-kinase interface. Thus, the
SH2 and catalytic domains of active Fes and Abl
pro-oncogenic kinases form integrated structures
essential for effective tyrosine kinase signaling.
INTRODUCTION
Protein domains aremodules that can be joined in new combina-
tions during evolution to create novel cellular functions. Once
covalently tethered, such domains can acquire specific intramo-
lecular interactions that yield selective allosteric regulation (Kur-
iyan and Eisenberg, 2007). These processes have been at work
in the evolution of multidomain cytoplasmic tyrosine kinases.
Most of these enzymes have a core unit comprised of a protein
kinase domain and an adjacent Src homology 2 (SH2) domain(Figure S1 available online), an ancient combination that likely
emerged at the dawn of phosphotyrosine (pTyr) signaling in
organisms such as Dictyostelium discoideum (Eichinger et al.,
2005). A likely role of this ancestral fusion of SH2 and kinase do-
mainswas to enhance the phosphorylation of specific substrates
(Moniakis et al., 2001). In metazoans, the SH2-kinase core is typ-
ically flanked by additional regulatory domains, such as SH3. In
addition to their positive role in kinase activity and substrate
recognition, the interaction domains of tyrosine kinases such
as Src, Abl, and ZAP-70 have also acquired an ability to sup-
press catalytic activity through intramolecular interactions. The
structural basis for these autoinhibitory effects has been ana-
lyzed in detail (Deindl et al., 2007; Nagar et al., 2003; Sicheri
et al., 1997; Xu et al., 1997). However, we lack a corresponding
understanding of the mechanisms by which the SH2 domain
synergizes with the tyrosine kinase domain in the active state.
The Fps/Fes cytoplasmic tyrosine kinase was identified as
a transforming protein encoded by avian (Fps) and mammalian
(Fes) retroviral oncogenes, in which retroviral Gag sequences
are fused to the N termini of cell-derived Fps/Fes products (Grof-
fen et al., 1983; Lee et al., 1980; Shibuya et al., 1980). We previ-
ously used insertion mutagenesis to identify domains required
for Fps catalytic and biological activities in the context of the
P130gag-fps viral (v) oncoprotein of Fujinami avian sarcoma
virus (Sadowski et al., 1986; Stone et al., 1984). This approach
revealed three regions that are important for v-Fps transforming
activity: the C-terminal tyrosine kinase domain, an adjacent se-
quence designated as the SH2 domain that modifies kinase ac-
tivity and substrate recognition, and an N-terminal domain (Nfps)
involved in membrane localization (Brooks-Wilson et al., 1989),
now annotated as a member of the extended FCH or F-BAR
domain family (Itoh and De Camilli, 2006).
Fps/Fes proteins do not possess an SH3 domain and,
consequently, are not autoinhibited through intramolecular
interactions in the fashion of Src and Abl tyrosine kinases
(Greer, 2002). In contrast, they may be regulated by reversibleCell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc. 793
membrane association and oligomerization mediated by the
F-BAR domain and by recruitment to specific subcellular sites
by the SH2 domain (Brooks-Wilson et al., 1989; Naba et al.,
2008; Read et al., 1997; Tsujita et al., 2006). The N-terminal
Gag sequences of v-Fps/Fes oncoproteins result in more stable
membrane localization and, consequently, in constitutive auto-
phosphorylation (Foster et al., 1985; Greer et al., 1994). For both
v-Fps (Weinmaster et al., 1984) and Fes (Hjermstad et al., 1993),
autophosphorylation in the kinase domain stimulates catalytic
activity.
Dipeptide insertions in the N-terminal region of the v-Fps SH2
domain cause a severe loss of both kinase and transforming
functions (DeClue et al., 1987; Sadowski et al., 1986). Taken
with the observation that the SH2 and kinase domains form
a 45 kDa protease-resistant fragment (Koch et al., 1989; Wein-
master and Pawson, 1982), such data have suggested that the
v-Fps SH2 domain undergoes an intramolecular interaction
with the kinase domain that stimulates catalytic activity. The
SH2 domains of v-Fps and human Fes also aid in substrate rec-
ognition (DeClue et al., 1987; Jucker et al., 1997; Koch et al.,
1989), potentially by binding pTyr sites on primed targets. Fps/
Fes proteins, therefore, provide amodel to study the cooperative
effects of interaction and catalytic domains in promoting the
kinase active state.
Mammals have two proteins with an F-BAR-SH2-kinase do-
main architecture, Fes and Fer. These have a range of functions,
including regulation of adherens junction stability, actin dynam-
ics, vesicular trafficking, and receptor internalization, mediated
by phosphorylation of substrates such as cortactin, Pecam-1,
and b-catenin (Greer, 2002; Sangrar et al., 2007; Udell et al.,
2006). In vivo, murine Fes and Fer regulate hemostasis and in-
nate immunity (Greer, 2002; Parsons and Greer, 2006; Parsons
et al., 2007).
Here, we identify the molecular mechanisms by which the
human Fes SH2 and kinase domains interact with one another
and with substrate to promote the active state. We show that
the linked SH2 and catalytic domains of the active Abl tyrosine
kinase, like Fes, act as a unit in which the SH2 domain stimulates
the adjacent kinase domain. These results show how tyrosine
kinase activity can be coupled to substrate recognition and
identify a common strategy by which the SH2 domains of
distinct cytoplasmic tyrosine kinases promote substrate
phosphorylation.
RESULTS
Determination of the Fes SH2-Kinase Structure
We investigated the structure of a polypeptide from human Fes
comprising a linker region N terminal to the SH2 domain, the
SH2 domain, and the C-terminal kinase domain (Figure 1A).
We obtained high yields for a single Fes construct (containing
residues I448 to the C terminus) in E. coli coexpressed with the
YopH tyrosine phosphatase (Seeliger et al., 2005). To explore
the mechanisms of kinase regulation and substrate recognition,
we solved structures of the unphosphorylated Fes SH2-kinase
unit both in the presence and absence of a kinase consensus
substrate peptide. In addition, we analyzed Fes SH2-kinase
that had been autophosphorylated on the kinase activation seg-794 Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc.ment (Y713) in complex with a substrate peptide. The three
structures were determined in complex with the ATP mimetic
kinase inhibitor staurosporine and were refined to low R factors
and acceptable geometry (Table S1). The binding mode of staur-
osporine to the ATP pocket is similar to structures reported pre-
viously (Bertrand et al., 2003); in addition, two molecules of
staurosporinewere identified in crystal contacts in Fes-substrate
complexes. The initial structure of unphosphorylated Fes SH2-
kinase revealed an active conformation, which was stabilized
by two sulphate ions that mimic binding of a pTyr ligand to the
SH2 domain, as well as activation segment phosphorylation.
This structure was well ordered, showing productive interactions
between the SH2 and kinase domains, and wewere able to trace
the entire chain; we refer to this structure as ‘‘active.’’ In contrast,
the other two structures have no ligand bound to the SH2 domain
and show disordered loop regions in the SH2 domain and in
the upper kinase lobe, indicative of an inactive conformation.
Composite analysis of all three structures indicates multiple
mechanisms for ordering of the activation segment.
Structural Overview of an Active Fes Conformation
An overview of unphosphorylated Fes SH2-kinase in its catalyt-
ically active conformation is shown in Figure 1B. In this active
configuration, the SH2 domain is stabilized by a sulphate ion,
which mimics the phosphate of a pTyr ligand by coordinating
a conserved SH2 domain arginine (R483), as well as R467 and
S485 (see Figure 5A). In addition, a sulphate ion is coordinated
by Y713 and R706 in the activation segment, thereby mimicking
autophosphorylation (see Figure 3B). The SH2 and kinase do-
mains form a stable unit linked by the N-terminal region of the
SH2 domain and polar interactions between the SH2 domain he-
lix aA and the catalytically important helix aC (Figures 1C, 2D,
and S2). In Fes/Fer family members, the linker region between
the SH2 and kinase domains is about 8 residues shorter when
compared to other cytoplasmic tyrosine kinases, constraining
the packing of the SH2 domain. The N terminus of the SH2 do-
main (462HGAI) intercalates between the central SH2 b sheet
and the loop region between strands b4 and b5 in the kinase
domain (Figures 2D and S3). This tight packing does not leave
room for bulky side chains, and the central glycine residue is
present in all Fes family members, suggesting that this domain
packing is conserved.
The second major interaction site is formed by a network of
acidic residues located in the SH2 helix aA (E469, E472) and
R609 in aC of the kinase. This arrangement suggests that the in-
teraction between the SH2 and kinase domains positions and
stabilizes aC in an active conformation, as indicated by the salt
bridge formed between the active site lysine (K590) and the con-
served aC glutamate (E607), as well as by low B values in loop
regions linking this helix (Figure 2D). The structure, therefore,
shows the SH2 domain forming an extensive interface with the
N lobe of the kinase domain that promotes the organization of
a functional kinase active site.
A Tight SH2-Kinase Interaction Is Required
for Fes Activity
To pursue the relevance of the observed interdomain inter-
actions, we studied the effects of mutating residues in the
SH2-kinase interface on human Fes activity. To this end, we
monitored Fes autophosphorylation and transphosphorylation
activity in transfected cells, using cortactin (residues 382–550)
fused to GST as an exogenous substrate (Figures 2A and
2B). In an effort to perturb the close interaction between the
SH2 and kinase domains, we mutated the conserved glycine
residue (G463) located in the tightly packed interface between
the SH2 N terminus and the kinase b4/b5 loop to valine (mutant
G/V). Introducing this bulky side chain would be expected to
sterically hinder alignment of the SH2 and kinase domains,
resulting in an altered domain packing. Wild-type (WT) and
G/V mutant full-length human Fes, each with an N-terminal
Flag epitope, were expressed in HEK293T cells together with
GST-cortactin. The WT protein was active as measured by
autophosphorylation and tyrosine phosphorylation of cotrans-
fected cortactin, whereas the G/V Fes mutant was completely
inactive (Figures 2A and 2B).
To extend this approach, we mutated residues involved in
the salt bridge network, which appear to position and stabilize
the kinase N-terminal lobe helix aC. In particular, we mutated
E469 and E472 in the SH2 domain aA helix to lysine either
individually or together (mutant EE/KK). The Fes E469K mutant
exhibited reduced tyrosine kinase activity, whereas the E472K
mutant was not significantly impaired (data not shown). Consis-
tent with this finding, the side chain of E472 was not visible in
the electron density and was assumed to be unstructured.
However, mutation of both E469 and E472 to lysine strongly re-
duced Fes kinase activity, suggesting that both side chains
contribute synergistically to this electrostatic interaction (Fig-
ures 2A and 2B). This is consistent with the observation that
the SH2-kinase domain interface shows a charge complemen-
tarity such that the surface of the SH2 domain interacting with
the kinase is mainly negatively charged, whereas the corre-
Figure 1. Structural Overview of Human Fes
(A) Domain architecture. The locations of the
F-BAR, SH2, and kinase domains are indicated.
The F-BAR domain contains the FCH and coiled-
coil (CC) sequences. The crystallized construct is
highlighted by arrows.
(B) Ribbon diagram representing the overall struc-
ture of the SH2-kinase domain unit. The main sec-
ondary structure elements are labeled.
(C) Surface representation of active Fes. The sur-
face is colored by electrostatic potential between
10 and +10 kcal/mol.
sponding kinase domain surface is posi-
tively charged (Figure S2). To demon-
strate that these mutations did not
disturb the structural integrity of Fes,
we sought to rescue the inactive double
mutant EE/KK by inverting the polarity
of the interface by simultaneously mutat-
ing R609 in the aC helix to glutamate. In-
deed, the triple mutant (mutant EER/
KKE) regained kinase activity to a level
approaching wild-type (Figures 2A and
2B), providing direct evidence that the
electrostatic interactions at the SH2-kinase interface are
functionally important. In support of the notion that the G/V
and EE/KK mutations have a selective effect on the SH2-kinase
interface, they did not alter the affinity of the isolated Fes
SH2 domain for a pTyr-containing peptide from ezrin
(VpYEPVSY). The SH2-kinase polypeptide had a similar affinity
for the ezrin phosphopeptide as did the isolated SH2 domain
(Figure S4).
We introduced the same mutations into a Myc-tagged
P130gag-fps oncoprotein and found that a G823V substitution,
analogous to the G/V mutation in Fes, completely inhibited
kinase activity (Figure S5). Of interest, the inactivating
RX15m v-Fps insertion that was isolated in the earlier muta-
genesis screen changes the tyrosine located 2 residues N
terminal to G823 to SRD and, therefore, likely inhibits kinase
activity by destabilizing the packing between the N terminus
of the SH2 domain and the b4/b5 loop of the kinase domain
(Figures 2C and S5). Single or double mutations of E829 and
E832 to lysine or alanine showed similar, albeit less pro-
nounced, effects as the corresponding substitutions in Fes
(at E469 and E472), and the activity of an EE/KK mutant
was restored by further substitution of E for R969 (EER/
KKE), equivalent to R609 in the Fes kinase aC helix (data
not shown). Supporting the importance of this interface in
v-Fps, the AX9m mutation in v-Fps inserts a LE dipeptide
between E832 and L833 in the SH2 aA helix, which likely dis-
turbs the electrostatic interface between the SH2 domain and
kinase aC helix. Thus, the RX15m and AX9m v-Fps insertion
mutations that originally identified the SH2 sequence as a
functional module map to the two primary elements that
interact with the kinase domain. Therefore, the SH2-kinase
interface revealed by structural analysis of human Fes is also
critical for the transforming activity of the v-Fps oncoprotein.Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc. 795
Figure 2. Activation of Fes Kinase Activity
by SH2 Domain Interactions
(A) The effect of mutations in the SH2 domain on
Fes kinase activity: HEK293T cells were cotrans-
fected with Flag-tagged Fes and GST-cortactin.
Cell lysates were immunoprecipitated with anti-
Flag and blotted with anti-pTyr to reveal auto-
phosphorylated (p) Flag-Fes (top panel) or with
anti-Flag (lower panel) as a control. WT indicates
wild-type Fes, and mutants are described in the
text.
(B) GST-cortactin was affinity purified from cells
coexpressing WT or mutant Fes proteins and blot-
ted either with anti-pTyr antibodies to measure
Fes-induced phosphorylation (p) (top panel) or
with anti-GST (bottom panel).
(C) Comparison of the N-terminal SH2 domain se-
quence of Fps/Fes orthologs. Insertions originally
used to identify the SH2 domain in v-Fps are indi-
cated (RX15m and AX9m) (Sadowski et al., 1986;
Stone et al., 1984). Conserved residues are high-
lighted in red and similar residues in yellow.
(D) Details of the Fes SH2-kinase interface. Resi-
dues important for the SH2 domain-kinase inter-
action are conserved in Fps/Fes family members
but not in other tyrosine kinases. Residues mu-
tated in this study are indicated by a green aster-
isk. Interactions of interface residues and the
involved secondary structure elements are shown
in the structure of active Fes. The alignment of
human sequences is colored as in (C).In summary, the residues at the SH2-kinase domain interface
stabilize an active conformation of the Fes kinase domain, in
part by positioning and stabilizing helix aC to form the active
site.
Substrate Binding and an Antiparallel b Sheet Stabilize
the Fes Activation Segment
To better understand Fes regulation, we also solved structures of
unphosphorylated Fes in the absence of phosphomimetic salt
ions and Fes in which the regulatory activation segment residue
(Y713) had been autophosphorylated in vitro (Table S1). In both
cases, a substrate peptide (IYESL) was cocrystallized. As ex-
pected, in phosphorylated Fes, the phosphorylated Y713 formed
a network of salt bridges and hydrogen bonds of the sort typi-
cally observed in activation segments of activated kinases
(Figure 3A). This links the conserved catalytic loop arginine
(R682) with the activation segment and additionally stabilizes
the active conformation through hydrogen bonds to R706 and
S716. These polar interactions are mimicked by the sulphate
ion present in active Fes (Figure 3B). Interestingly, the activation
segment of unphosphorylated Fes crystallized in the absence of
sulphate ions assumed a similar conformation, stabilized by hy-
drogen bonds to the Y713 hydroxyl group, suggesting that the796 Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc.Fes activation segment is quite stable in the absence of tyrosine
phosphorylation.
Two structural features contribute to this stability. First, the ac-
tivation loop forms a short antiparallel b sheet with the loop re-
gion linking the helices aEF with aF in the kinase C lobe. Interest-
ingly, this b sheet is present in most active (phosphorylated)
tyrosine kinases in addition to the constitutively active Ser/Thr
kinase MPSK1 (Eswaran et al., 2008) and in all Fes structures
presented here (Figure S6). Second, binding of the substrate
peptide also induces a b sheet secondary structure between
the substrate peptide and a strand in the activation segment
(bI), with typical main chain hydrogen bond interactions. The
activation segment in active Fes showed significantly higher
temperature factors than in either of the Fes-substrate com-
plexes, indicating the stabilizing effect of substrate binding
(Figure 3C). A similar antiparallel sheet interaction is also present
in insulin receptor-substrate complexes, suggesting that stabili-
zation of the activation segment by substrate binding is a more
widespread mechanism of tyrosine kinase activation (Figure S6).
Fes is only distantly related to tyrosine kinases of known sub-
strate specificity. We used a degenerate peptide library and
a peptide array comprising all single substitutions of a known
substrate peptide (EAEIYEAIE) to determine the peptide
sequence preferentially recognized by the Fes active site
(Figure S7). The two screens revealed that Fes prefers substrates
with bulky aliphatic residues at the position N terminal to the sub-
strate tyrosine (position1), an acidic or phosphorylated residue
at position +1, and hydrophobic residues at position +3. The
structure of Fes in complex with its consensus peptide IYESL
supports the peptide library results (Figures 4 and S7). Selectivity
for hydrophobic interactions in substrate positions 1 and +3
can be explained by binding of the corresponding substrate res-
idues isoleucine and leucine to hydrophobic pockets on the Fes
kinase, and selectivity for acidic residues in position +1 is due to
formation of a hydrogen bond with N766 located in helix aG. The
determined substrate specificity corresponds well to known
exogenous Fes-substrate sites (Greer, 2002).
Fes Is Stabilized by Ligand Binding
to Its SH2 Domain
In the latter two structures, crystallized in the absence of phos-
phomimetic salt ions, there was no ligand bound to the SH2 do-
main. A striking feature of both structures was the large degree of
disorder in SH2 domain loop regions as well as in the loop con-
necting the sheet b3 with aC. In addition, helix aC showed very
high temperature factors, indicating a high degree of mobility
of this regulatory element (Figures 3C and 5B). In contrast, the
sulphate ion occupying the pTyr-binding site of the SH2 domain
in the active Fes structure formed a network of salt bridges
Figure 3. Conformation of the Fes Activa-
tion Segment
(A) Superimposition of the activation segment
in active Fes (gray) and the phosphorylated
Fes-substrate complex. Hydrophilic interactions
formed by the phosphatemoiety and the substrate
tyrosine are indicated by yellow dots. The antipar-
allel b sheet formed at the tip of the activation seg-
ment is labeled as b-A-loop, and the substrate
peptide is shown as a red ribbon. The induced
b sheet present in the substrate complex (bI) is
also shown.
(B) Interactions of the activation segment Y713 in
unphosphorylated (left), active (ligating a sulphate
ion; middle), and phosphorylated (right) Fes.
A 2Fo – Fc electron density map around the inter-
acting residues is also shown contoured at 2s.
(C) Schematic drawing of the Fes main chain. Re-
gions with high temperature factors are shown by
an increasing radius of the backbone. The activa-
tion segment is highlighted in purple; aC, in pink;
the SH2 domain, in green; and the substrate pep-
tide (in the phosphorylated Fes structure), in
orange. Note the absence of ordered loop regions
in the SH2 domain and kinase N lobe of phosphor-
ylated Fes.
typically observed in SH2 domain phos-
phopeptide complexes, correlating with
stabilization and ordering of the SH2 do-
main and aC (Figures 5A and 5B). The
high flexibility of residues in the SH2-ki-
nase domain interface in the absence of
an SH2 ligand suggested that Fes activity and SH2 domain li-
gand binding are coupled. To pursue this model, we substituted
R483 in the SH2 pTyr-binding pocket with methionine (mutant
R/M), which abolishes pTyr recognition (Figure S4A). The R/M
mutant failed to autophosphorylate in transfected cells and
had a significantly reduced ability to transphosphorylate cortac-
tin (Figures 2A and 2B). We used NMR spectroscopy to assess
whether this substitution might affect SH2 residues at the inter-
face with the kinase domain. An HSQC NMR spectrum of an
15N-labeled sample of the isolated R/M mutant Fes SH2 domain
revealed chemical shift changes of amide resonances of the
critical interface residues G463 and E469 and nearby residues,
as compared with the wild-type SH2 domain (Figure 5C). While
these changes are ligand independent, the low activity of the
R/Mmutation, together with the structural data, suggests a cou-
pling between SH2 domain pTyr binding and the catalytically
active Fes conformation.
In the active Fes structure, the pTyr-binding site of the Fes SH2
domain is only about 30 A˚ distant from the active site of the ki-
nase domain. Since peptides bound to the activation segment
and the SH2 domain should be in the same N- to C-terminal ori-
entation, the Fes phosphorylation site and the pTyr that recog-
nize the Fes SH2 domain could, in principle, be connected within
the same polypeptide chain by a short intervening sequence (see
Figure 7). To test this model, we synthesized primed substrate
peptides, each containing a C-terminal phosphorylated SH2Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc. 797
domain-binding site, linked by a polyglycine spacer of variable
length to an unphosphorylated tyrosine located in a minimal
Fes consensus substrate motif. We incubated these peptides
with purified Fes SH2-kinase to determine whether there is an
optimal spacing that favors phosphorylation of the latter site. A
primed peptide with a linker of 10 glycine residues was a signifi-
cantly better substrate than peptides with shorter or longer
spacers (Figure S8). These data define a mechanism through
which the Fes SH2 domain activates kinase function and recruits
substrates. The SH2 domain, the kinase domain, and substrate
apparently interact cooperatively to yield a functional Fes kinase
complex.
A Stimulatory SH2-Kinase Domain Interaction in the Abl
Tyrosine Kinase
Is the active SH2-kinase unit a broader feature of related cyto-
plasmic tyrosine kinases? To address this issue, we investigated
the role of SH2-kinase interactions in determining the activity
and substrate recognition of the pro-oncogenic c-Abl tyrosine
kinase. In the autoinhibited conformation, the Abl SH2 domain
docks onto the back of the C lobe of the kinase and, in conjunc-
tion with the SH3 domain, suppresses kinase activity (Hantschel
et al., 2003; Nagar et al., 2003). Upon activation, the SH2 and ki-
nase domains must be reoriented, and small angle X-ray scatter-
ing (SAXS) analysis of a constitutively active Abl variant (P242E/
P249E, Abl-PP) has revealed that the SH3, SH2, and kinase do-
mains are positioned in an extended arrangement (Nagar et al.,
2006). Furthermore, crystallographic analysis identified a form
of Abl consistent with the SAXS shape reconstruction, in which
the SH2 domain forms an extensive interface with the N lobe of
the kinase domain, with tight contacts formed between I164 in
the SH2 domain and T291/Y331 in the kinase N lobe (Nagar
et al., 2006; see Figure 6A). Simultaneous mutation of all three in-
terface residues (I164E/T291E/Y331A [mutant ITY/EEA]) strongly
Figure 4. Substrate Interaction with the Fes
Kinase Domain
(A) Details of the substrate peptide (IYESL) interac-
tion with the kinase domain.
(B) Structure of the Fes-substrate complex show-
ing a detail of the location of the peptide (shown in
sticks). The surface has been colored by electro-
static potential between 10 and +10 kcal/mol.
(C) 2Fo – Fc electron density map contoured at 2s
around the substrate peptide residues.
reduced the activity of purified Abl pro-
teins (Nagar et al., 2006) and abrogated
Abl autophosphorylation and tyrosine
phosphorylation of exogenous sub-
strates in transfected cells, as well as ab-
lating in vitro kinase activity, even in the
presence of the most strongly activating
Abl mutations (G2A/PP) (Figures 6B and
S9A). However, since the two mutated
N-lobe residues are close to the active
site, these mutations could potentially
cause an intrinsic defect in the kinase do-
main (Nagar et al., 2006). Indeed, substitution of either N-lobe
residue alone (T291E or Y331A) impaired Abl kinase activity
due either to disturbance of the SH2-kinase interface or a direct
effect on catalytic activity (Figure S9C).
Therefore, we tested the effect of mutating the SH2 residue
I164 to glutamate (mutant I/E) in the absence of further
substitutions in the kinase N lobe by measuring Abl tyrosine ki-
nase activity in transfected HEK293 cells and in vitro. For both
wild-type c-Abl and activated Abl-PP, incorporation of the SH2
I164E mutation dramatically impaired Abl kinase activity and
substrate phosphorylation, and only a slight further reduction
was detected upon additional mutation of T291 and Y331 in
the kinase domain (Figures 6C and S9B). These data suggest
that full Abl activity requires the observed I164-mediated interac-
tion of the SH2 domain with the kinase domain and that disrup-
tion of this interface severely compromises phosphorylation of
Abl substrates in cells. Phosphotyrosine recognition by the
SH2 domainmay alsomodulate kinase activity since substitution
of the conserved R171 in the SH2 domain with leucine, which
abrogates pTyr binding, compromises Abl kinase activity and
substrate phosphorylation (Figures S9B and S9C).
In contrast to the I164E mutation, substitution of Y158 in the
SH2 domain with aspartate (mutant Y/D), which interferes with
the autoinhibitory interaction of the SH2 domain with the kinase
C lobe (Hantschel et al., 2003), increased the in vitro kinase ac-
tivity of an Abl-PP mutant (Figure S9C). These data support the
concept that the Abl SH2 domain interacts with the C lobe and
N lobe of the kinase through distinct surfaces with opposing
effects on catalytic activity.
To test whether the positive effect of the SH2 domain on cat-
alytic activity is an intrinsic property of the SH2-kinase unit or re-
quires additional Abl sequences, we compared the in vitro activ-
ity of the isolated c-Abl kinase domain (KD) to a polypeptide
containing the SH2 and kinase domains (SH2-KD) (Figures798 Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc.
S9D and S9E). HA-tagged Abl proteins were precipitated from
HEK293 cells and assayed for phosphorylation of an optimal
Abl substrate peptide. The SH2-KD protein was almost 4-fold
more active than the kinase domain alone due to an effect on
vmax (Figure 6D). This stimulatory effect of the SH2 domain was
entirely suppressed by inclusion of the I164E SH2 mutation.
These results argue that, as in Fes, a specific SH2-kinase inter-
action is required for efficient Abl catalytic activity and substrate
phosphorylation in cells.
DISCUSSION
An Activating Role of the Fes SH2 Domain
The SH2 domain was identified in the v-Fps oncoprotein as
a noncatalytic module that exerts positive effects on the activity
and substrate specificity of the adjacent tyrosine kinase domain
(Sadowski et al., 1986; Stone et al., 1984). The structure of the
active Fes SH2-kinase unit reveals tight packing of the SH2
domain with the kinase domain. This interaction is additionally
maintained by electrostatic interactions between the SH2 helix
aA and kinase helix aC, which position and stabilize aC in an
active conformation. Mutations that disrupt this SH2-kinase in-
terface, including targeted substitutions in Fes as well as the
RX15m and AX9m insertion mutants in v-Fps, impair or eliminate
kinase activity.
Stabilization of the kinase aC helix by interactions with helical
elements is a common regulatory mechanism for protein kinases
(Lei et al., 2005; Zhang et al., 2006). Here, we report a newmode
of activation in which aC is positioned by a helix present in the
Figure 5. Stabilization of the Fes SH2
Domain by Ligand Binding
(A) Coordination of a sulphate ion in the SH2 phos-
photyrosine-binding site in active Fes and 2Fo – Fc
electron density map contoured at 2s around res-
idues that coordinate the sulfate ion.
(B) Superimposition of active Fes (green) and Fes
phosphorylated at the activation segment Y713
with an unligated SH2 domain (gray). Structural
changes associated with ligand binding to the
SH2 domain are indicated by arrows.
(C) Effect of the R/M mutation in the Fes SH2
domain measured by NMR. Overlay of 1H-15N
HSQC spectra of wild-type (black) and mutant
R/M (green) isolated Fes SH2 domain, with regions
of the spectra relating to residues located in the
SH2-kinase domain interface indicated in the right
two panels (R483*: side chain resonance).
Residues that showed significant chemical shift
changes in the spectra of the R/Mmutant SH2 do-
main, as compared to wild-type, are depicted in
green on the Fes SH2 domain surface in the left
panel. Blue indicates the position of R483. Helix
aC and the loop between strands b4 and b5 of
the kinase domain are shown in orange.
SH2 domain; unusually, the activating
helix is not aligned parallel with aC but
is oriented perpendicular to it, maintained
by long-range electrostatic interactions.
The importance of the interaction be-
tween SH2 aA and kinase aC is directly shown by the functional
rescue of a kinase-deficient mutant by reversing the charge
polarity of residues at the interface.
In contrast to the active conformation, Fes with an unligated
SH2 domain is partially disordered, containing unstructured re-
gions in SH2 domain loops and a highly mobile helix aC.We infer
that binding of a phosphorylated ligand to the SH2 domain sta-
bilizes the SH2-kinase interaction and, thereby, the active con-
formation of the catalytic domain. Our data also suggest that
the SH2 domain can play a role in substrate recognition by bind-
ing a phosphorylated target and orienting a substrate tyrosine to
the active site. Fes substrates such as cortactin and HS1 have
multiple pTyr sites separated by spacers of a suitable length
for such docking-dependent phosphorylation. In support of this
scheme, genetic and cellular data indicate that Fps/Fes proteins
act downstream of, or in conjunction with, Src family kinases,
which could generate primed sites for Fes activation (Murray
et al., 2006; Udell et al., 2006).
Coordinate Effects of SH2-Kinase Interactions,
Autophosphorylation, and Substrate
Recognition in Fes Activation
A schematic model of Fes activation is shown in Figure 7. In the
inactive state, we propose that the SH2 domain and the N lobe of
the kinase domain are significantly disordered, and, as a conse-
quence, the aC helix of the kinase N lobe is not optimally posi-
tioned for catalysis. In addition, the activation segment of the
kinase domain is relatively unstable. However, localization to
specific membrane sites promotes the active form of the kinaseCell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc. 799
Figure 6. The Abl SH2 Domain Stimulates
Kinase Activity
(A) Ribbon representation of the active conforma-
tion of Abl (PDB entry 1OPL chain B) and close-up
view of SH2-kinase domain interface. Critical
interface residues (I164, T291, and Y331) are
shown. R171 highlights the location of the pTyr-
binding site in the SH2 domain.
(B) SH2-kinase interface residues are required for
in vivo Abl activity. HEK293 cells were transfected
with c-Abl (WT) or the activated Abl variants PP (*)
or G2A/PP (**) or with the corresponding ITY/EEA
mutants, as indicated. Cells were lysed, and
anti-Abl immunoprecipitates were analyzed by
anti-Abl and anti-pTyr (pY) immunoblotting (lower
panels). The histograph shows the in vitro kinase
activity (mean of two experiments done in dupli-
cate, black bars) and levels of autophosphoryla-
tion (mean of two immunoprecipitations, gray
bars) of the Abl constructs relative to c-Abl and
corrected for endogenous c-Abl levels.
(C) I164 in the Abl SH2 domain is required for
efficient kinase activity (WT = c-Abl, * = Abl-PP;
corresponding mutants are indicated).
(D) The SH2 domain is necessary and sufficient to
stimulate in vitro Abl kinase activity. Purified Abl
proteins (see also Figures S9D and S9E) were
evaluated for kinase activity in the presence of
50 mM ATP and the indicated concentrations of
an optimal Abl substrate peptide. The Km and
vmax values are given below the graph.through a series of linked devices. For one, clustering induces
intermolecular autophosphorylation, which stabilizes an active
conformation of the activation loop. In addition, juxtaposition
with potential targets allows a primed substrate or scaffold to
bind and stabilize the SH2 domain, thereby promoting a produc-
tive interaction with the kinase N lobe that locks the aC helix in an
active configuration. The active state could be further stabilized
by association of a substrate peptide with the activation loop of
the kinase domain. According to this model, Fes acts as a coin-
cidence detector that is only fully activated by the combined ef-
fects of its interactions with membrane, a pTyr docking site, and
substrate. Fes may, thereby, achieve substrate selectivity in part
by coupling target recognition to kinase activation.800 Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc.The N-terminal Fps/Fes F-BAR domain forms oligomers and
interacts with phospholipids (Greer, 2002; Tsujita et al., 2006),
and the F-BAR domains of PCH proteins make extended fila-
ments implicated in membrane tubulation and endocytosis
(Frost et al., 2008). We speculate that recruitment of the F-BAR
domain to the membrane clusters Fps/Fes proteins in a fashion
that promotes autophosphorylation, and it positions the SH2-
kinase unit to phosphorylate targets such as cortactin that are
involved in cytoskeletal reorganization and vesicular trafficking.
Regulatory Roles of the SH2 Domain
The SH2 domains of cytoplasmic tyrosine kinases can have two
general types of regulatory effects. In the kinase-active state, theFigure 7. Cartoon Representation of Fes Activa-
tion
In its unligated and unphosphorylated state, the Fes SH2
domain (blue), aC (red), and activation segment (purple)
are significantly disordered (left). Binding of a primed
peptide (yellow) stabilizes the SH2 domain, leading to
a productive orientation of the SH2 domain, with respect
to the kinase domain, and stable positioning of aC
(middle). Phosphorylation of the activation segment at
Y713 and binding of the substrate molecule to the kinase
domain stabilizes the activation segment in a conformation
suitable for catalysis (right).
SH2 domain can direct subcellular localization and substrate re-
cruitment and promote an active conformation of the adjacent
catalytic domain. The Fes kinase appears optimized for this pos-
itive mode of regulation. Conversely, the SH2 domain of kinases
such as Src, Abl, and ZAP-70 can act in conjunction with an
additional SH2 or SH3 domain to maintain an inactive state
through intramolecular interactions with the catalytic domain
(Figure S10). However, in these latter kinases, the SH2 domain
is bifunctional in the sense that it is also critical for active signal-
ing. For example, upon activation, the Abl SH2 and SH3 domains
redistribute from their autoinhibitory positions on the backside of
the kinase domain to adopt an extended conformation, with the
SH2 domain contacting the tip of the kinase N-terminal lobe
through a conserved isoleucine residue. We find that this latter
interface allows the Abl SH2 domain to stimulate catalytic activ-
ity. The Abl SH2 domain binds primed substrates such as
p130cas and enhances their processive phosphorylation (Mayer
et al., 1995), suggesting that, as in Fes, the Abl SH2 domain
has functions in promoting both substrate recognition and
catalytic activity. These data are consistent with a more general
role for the SH2-kinase unit in downstream signaling by
cytoplasmic tyrosine kinases.
As with autoinhibitory interactions, the mechanisms by which
the SH2 domain contributes to the active state likely vary from
kinase to kinase. The SH2 domains of active Fes and Abl have
distinct interfaces and orientations with respect to the kinase do-
main. In the active conformation of C-terminal Src kinase (Csk),
the SH2 and SH3 domains bind on opposing sides of the kinase
N lobe, and their deletion results in100-fold reduction in the kcat
of Csk, demonstrating that the SH3-SH2 domains have an acti-
vating function (Ogawaet al., 2002;Sondhi andCole, 1999). Inter-
estingly, this effect is potentiated by phosphopeptide binding
to the SH2 domain (Lin et al., 2006). In the case of the Tec fam-
ily member Btk, a low-resolution structural analysis by SAXS
has suggested an extended linear arrangement of domains
(Marquez et al., 2003), while mutagenesis data suggest that
the SH2 domain and SH2-kinase linker of Tec family members
stabilize aC in an active conformation (Joseph et al., 2007).
Finally, active structures of Src family kinases show little
interaction with the catalytic domain; since the isolated kinase
domain is fully active when phosphorylated, the SH2 domain
may primarily target the kinase to an appropriate site and pro-
mote processive phosphorylation without directly influencing
kinase activity (Cowan-Jacob et al., 2005; Scott and Miller,
2000). Thus, the relative orientation of the SH2 domain with
respect to the kinase domain could define its preference for
specific substrates or scaffolds and the extent to which SH2
domain ligands control kinase activity. Our data for Fes provide
a precise molecular mechanism by which an SH2 domain stim-
ulates kinase activity and substrate recognition, and we show
that a functionally similar SH2-kinase unit is employed for ac-
tive Abl signaling.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
cDNAs encoding human Fes (NP_001996) were cloned into pNIC28-Bsa4. Ex-
pression constructs were transformed into phage-resistant E. coli BL21(DE3)-R3 cotransformed with an expression vector encoding Yersinia phosphatase
YopH (plasmid kindly provided by J. Kuriyan) (Seeliger et al., 2005). Cells
were grown and Fes SH2-kinase proteins were purified according to previ-
ously described procedures (see Supplemental Data for details).
Protein Phosphorylation
Protein samples were dialyzed overnight (50 mM HEPES [pH 7.5], 500 mM
NaCl, and 5% glycerol), and phosphorylation was carried out by addition of
10 mM DTT, 10 mM Na3VO4, 2 mM (NH4)2SO4, 10 mM MgCl2, 2 mM ATP,
and 5 mM MnCl2. Phosphorylated Fes was purified by gel filtration, concen-
trated to 10 mg/ml, and used for crystallization. The identities of recombinant
proteins were confirmed using electrospray mass spectrometry (ESI-TOF)
(Agilent).
Mammalian Expression Constructs
Wild-type p130Gag-Fps and the RX15m and AX9m mutants (Stone et al., 1984)
were subcloned into the vector pRK5-myc (Winberg et al., 2000). Full-length
human Fes was cloned into the vector pCMV7.1-3xFlag (Sigma, St. Louis,
MO). Site-directed mutagenesis was performed using the QuickChange
II XL Kit (Stratagene, La Jolla, CA) following the manufacturer’s directions.
A GST-tagged C-terminal fragment of human cortactin (residues 382–550,
accession Q14247) was prepared by PCR from cDNA (accession BC008799)
and cloned into pEBG vector (gift fromC. Duckett, University of MichiganMed-
ical School, Ann Arbor).
Tissue Culture
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% (vol/vol) fetal bovine serum, 100 units/ml penicillin
G sodium, and 100 mg/ml streptomycin and incubated at 37C, 5% CO2.
In Vivo Kinase Assay
Flag-tagged Fes or Myc-tagged p130Gag-Fps and mutants thereof were co-
transfected with GST-cortactin into HEK293T cells. After 24 hr, cells were
lysed with NP-40 cell lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl,
1% NP-40, and 1 mM EDTA) that contained 1 mM phenylmethylsulfonyl fluo-
ride, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and 10 mg/ml pepstatin A. Cell
lysates, normalized for protein concentration, were used in anti-Flag M2
antibody-agarose (Sigma) or anti-Myc antibody immunoprecipitations or glu-
tathione sepharose affinity precipitations. Associated proteins were resolved
using SDS-PAGE and analyzed by western blotting using anti-Flag M2
(Sigma), anti-c-Myc 9E10 (Santa Cruz), HRP-conjugated anti-GST (Santa
Cruz), or anti-pTyr 4G10 (Upstate) antibodies.
Peptide Synthesis
Synthetic peptides were prepared using Fmoc (9-fluorenyl methoxycarbonyl)
solid-phase chemistry. Phosphotyrosine was incorporated using the N-
fluorenylmethyloxycarbonyl-O-phospho-L-tyrosine derivative. Peptides were
purified using reverse-phase HPLC, and the authenticity was confirmed by
mass spectrometry.
Crystallization and X-Ray Data Collection
Sitting drops were set up using a Mosquito crystallization robot (TTP Labtech,
Royston UK). Staurosporine and peptides were added to a final concentration
of 1 mM and 250–300 mM, respectively. The active form (I) was crystallized
from 0.2 M Na2SO4, 0.1 M bis-tris propane (pH 7.5), 20% PEG 3350, and
10% ethylene glycol. The unphosphorylated form (II) gave crystals from 20%
PEG 3350 and 0.1 M sodium malate in the presence of the peptide Ac-IYESL.
The phosphorylated protein (III) gave crystals from 30% mPEG 2000 and
0.15 M NaBr in the presence of the peptide Ac-IYESL. Crystals were soaked
in a cryoprotectant solution containing the crystallization condition supple-
mented by 25% ethylene glycol and were flash-frozen in liquid nitrogen.
Data sets were collected at the X10 beam line (Swiss Light Source) using
a MAR225 detector at a single wavelength of 0.9807 nm in the case of I or in
house on a Rigaku FRE rotating anode equipped with a Rigaku HTC image
plate detector in the cases of II and III.Cell 134, 793–803, September 5, 2008 ª2008 Elsevier Inc. 801
Data Processing, Molecular Replacement, and Refinement
Data were indexed and integrated using MOSFLM (Leslie and Powell, 2007)
andwere scaled using SCALA (Evans, 2007). The structure of I was determined
using molecular replacement and PHASER (McCoy et al., 2005) using an en-
semble comprising PDB accession codes 1OPL, 1OPK, and 2FO0. All struc-
tures were refined using REFMAC5 (Murshudov et al., 1997). Thermal motions
were analyzed using TLSMD (Painter and Merritt, 2006), and hydrogen atoms
were included in late refinement cycles. Themodels and structure factors have
been deposited with PDB accession codes: 3BKB (active Fes [I]), 3CBL (Fes/
Ac-IYESL [II]), and 3CD3 (pY713-Fes/Ac-IYESL [III]). Protein ribbon graphic
representations were created using PYMOL (version 0.98) (DeLano, 2002).
ACCESSION NUMBERS
The models and structure factors of Fes have been deposited in the Protein
Data Bank with the PDB accession codes 3BKB (active Fes), 3CBL (Fes/
Ac-IYESL), and 3CD3 (pY713-Fes/Ac-IYESL).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, one
table, and ten figures and can be found with this article online at http://www.
cell.com/cgi/content/full/134/5/793/DC1/.
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